Exact Mass: 318.0571

Exact Mass Matches: 318.0571

Found 51 metabolites which its exact mass value is equals to given mass value 318.0571, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Prekinamycin

11-Diazonio-4,10-dihydroxy-2-methyl-9-oxo-benzo[b]fluoren-5-olate

C18H10N2O4 (318.0641)


   

Melanin

6,14-dimethyl-4,12-diazapentacyclo[8.6.1.1²,⁵.0¹³,¹⁷.0⁹,¹⁸]octadeca-1(17),2,5,9(18),10,13-hexaene-7,8,15,16-tetrone

C18H10N2O4 (318.0641)


Dermal melanin is produced by melanocytes, which are found in the stratum basale of the epidermis. Although human beings generally possess a similar concentration of melanocytes in their skin, the melanocytes in some individuals and races more frequently or less frequently express the melanin-producing genes, thereby conferring a greater or lesser concentration of skin melanin. Some individual animals and humans have no or very little melanin in their bodies, which is a condition known as albinism. Higher eumelanin levels also can be a disadvantage, however, beyond a higher disposition toward vitamin D deficiency. Dark skin is a complicating factor in the laser removal of port-wine stains. Effective in treating fair skin, lasers generally are less successful in removing port-wine stains in Asians and people of African descent. Higher concentrations of melanin in darker-skinned individuals simply diffuse and absorb the laser radiation, inhibiting light absorption by the targeted tissue. Melanin similarly can complicate laser treatment of other dermatological conditions in people with darker skin. Under the microscope melanin is brown, non-refractile and finely granular with individual granules having a diameter of less than 800 nanometers. This differentiates melanin from common blood breakdown pigments which are larger, chunky and refractile and range in color from green to yellow or red-brown. In heavily pigmented lesions, dense aggregates of melanin can obscure histologic detail. A dilute solution of potassium permanganate is an effective melanin bleach. Pigments causing darkness in skin, hair, feathers, etc. They are irregular polymeric structures and are divided into three groups: allomelanins in the plant kingdom and eumelanins and phaeomelanins in the animal kingdom. Because melanin is an aggregate of smaller component molecules, there are a number of different types of melanin with differing proportions and bonding patterns of these component molecules. Both pheomelanin and eumelanin are found in human skin and hair, but eumelanin is the most abundant melanin in humans, as well as the form most likely to be deficient in albinism. Freckles and moles are formed where there is a localized concentration of melanin in the skin. They are highly associated with pale skin. Melanin is a biopolymer and a neuropeptide. In the early 1970s, John McGinness, Peter Corry, and Peter Proctor reported that melanin is a high-conductivity organic semiconductor (Science, vol 183, 853-855 (1974)). Studies revealed that melanin acted as a voltage-controlled solid-state threshold switch. Further, it emitting a flash of light electroluminescence when it switched. Dermal melanin is produced by melanocytes, which are found in the stratum basale of the epidermis. Although human beings generally possess a similar concentration of melanocytes in their skin, the melanocytes in some individuals and races more frequently or less frequently express the melanin-producing genes, thereby conferring a greater or lesser concentration of skin melanin. Some individual animals and humans have no or very little melanin in their bodies, which is a condition known as albinism.

   

DMPP

1,1-Dimethyl-4-phenylpiperazin-1-ium iodide

C12H19IN2 (318.0593)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005731 - Ganglionic Stimulants D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists

   

Clotiazepam

5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno[2,3-e][1,4]diazepin-2-one

C16H15ClN2OS (318.0594)


Clotiazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative, not approved for sale in the U.S. or Canada, but has been approved in the U.K. It is a schedule IV drug in Canada.Clotiazepam acts at the benzodiazepine receptors (BZD). This agonizes the action of GABA, increasing the frequency of opening of the channel chlorinates and penetration of the ions chlorinates through the ionophore. Increase in membrane polarization decreases the probability of discharge of neurons. N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Fenofibric acid

2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid

C17H15ClO4 (318.0659)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.

   

Fenofibric acid

2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-propionic acid

C17H15ClO4 (318.0659)


A monocarboxylic acid that is 2-methylpropanoic acid substituted by a 4-(4-chlorobenzoyl)phenoxy group at position 2. It is a metabolite of the drug fenofibrate. C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 337 CONFIDENCE standard compound; INTERNAL_ID 2056 Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.

   

Methyl 4-cyano-5-(tetrahydro-1H-pyrrol-1-yl)-3-(2-thienyl)thiophene-2-carboxylate

Methyl 4-cyano-5-(tetrahydro-1H-pyrrol-1-yl)-3-(2-thienyl)thiophene-2-carboxylate

C15H14N2O2S2 (318.0497)


   

2-Dichloro-acetamido-3-(p-acetamidophenyl)-propan-1-ol

2-Dichloro-acetamido-3-(p-acetamidophenyl)-propan-1-ol

C13H16Cl2N2O3 (318.0538)


   

6-Sulfo-chinovose-glycerin|6-Sulfo-chinovose-glycerol|6-Sulfo-O-alpha-D-chinopyranosyl-(1->1)-glycerin|6-Sulfo-O-alpha-quino-pyranosyl-(1->1)-glycerin

6-Sulfo-chinovose-glycerin|6-Sulfo-chinovose-glycerol|6-Sulfo-O-alpha-D-chinopyranosyl-(1->1)-glycerin|6-Sulfo-O-alpha-quino-pyranosyl-(1->1)-glycerin

C9H18O10S (318.0621)


   

Haemofluorone A

Haemofluorone A

C19H10O5 (318.0528)


   

Haemofluoron B

Haemofluoron B

C19H10O5 (318.0528)


   

Haemodordioxolane

Haemodordioxolane

C19H10O5 (318.0528)


   

Haemofluorone B

Haemofluorone B

C19H10O5 (318.0528)


   
   

clotiazepam

5-(2-chlorophenyl)-7-ethyl-1-methyl-1H,2H,3H-thieno[2,3-e][1,4]diazepin-2-one

C16H15ClN2OS (318.0594)


N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

4-(5-CHLORO-2-METHOXYBENZOYL)BENZOIC ACID ETHYL ESTER

4-(5-CHLORO-2-METHOXYBENZOYL)BENZOIC ACID ETHYL ESTER

C17H15ClO4 (318.0659)


   

Vincofos

2,2-dichloroethenyl methyl octyl phosphate

C11H21Cl2O4P (318.0554)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

3,5-bis(trifluoromethyl)benzophenone

3,5-bis(trifluoromethyl)benzophenone

C15H8F6O (318.0479)


   

3-Amino-4-nitrophenol

3-Amino-4-nitrophenol

C12H16Cl2N4O2 (318.065)


   

(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl4-methylbenzene sulfonate

(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)methyl4-methylbenzene sulfonate

C13H18O5S2 (318.0596)


   

Propylphosphonic anhydride

Propylphosphonic anhydride

C9H21O6P3 (318.0551)


   
   

3,4-di(trifluoromethyl)benzophenone

3,4-di(trifluoromethyl)benzophenone

C15H8F6O (318.0479)


   

5-BROMO-3-(2-PHENYL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

5-BROMO-3-(2-PHENYL-PYRROLIDIN-1-YL)-PYRAZIN-2-YLAMINE

C14H15BrN4 (318.048)


   

4-(4-CHLORO-7-(METHYLSULFONYL)-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDIN-2-YL)MORPHOLINE

4-(4-CHLORO-7-(METHYLSULFONYL)-6,7-DIHYDRO-5H-PYRROLO[2,3-D]PYRIMIDIN-2-YL)MORPHOLINE

C11H15ClN4O3S (318.0553)


   

3,3-bis(trifluoromethyl)benzophenone

3,3-bis(trifluoromethyl)benzophenone

C15H8F6O (318.0479)


   

4-[3,5-bis(trifluoromethyl)phenyl]benzaldehyde

4-[3,5-bis(trifluoromethyl)phenyl]benzaldehyde

C15H8F6O (318.0479)


   

2-Methyl-2-propanyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8- carboxylate

2-Methyl-2-propanyl 3-bromo-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8- carboxylate

C12H19BrN2O3 (318.0579)


   

1-[2-(Z)-Methoxyimino-2-(2-aminothiazol-4-yl)acetyl]benzotrizole-3-oxide

1-[2-(Z)-Methoxyimino-2-(2-aminothiazol-4-yl)acetyl]benzotrizole-3-oxide

C12H10N6O3S (318.0535)


   

praseodymium(iii) isopropoxide

praseodymium(iii) isopropoxide

C9H21O3Pr (318.0567)


   

Disulfide,1,2-di-2-naphthalenyl

Disulfide,1,2-di-2-naphthalenyl

C20H14S2 (318.0537)


   

Flutemazepam

Flutemazepam

C16H12ClFN2O2 (318.0571)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone

2-Chloro-1-[3-(4-methylphenyl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]ethanone

C16H15ClN2OS (318.0594)


   

N-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-1,2,4-triazol-3-yl}-N,N-dimethyliminoformamide

N-{1-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-1H-1,2,4-triazol-3-yl}-N,N-dimethyliminoformamide

C11H10ClF3N6 (318.0608)


   

Benzo(1,2-b:4,5-b)bis(1)benzothiophene, 6,12-dimethyl-

Benzo(1,2-b:4,5-b)bis(1)benzothiophene, 6,12-dimethyl-

C20H14S2 (318.0537)


   

4-methylphenyl 5-phospho-alpha-D-ribofuranoside

4-methylphenyl 5-phospho-alpha-D-ribofuranoside

C12H15O8P-2 (318.0505)


   

[(2S,3S,4S,5R,6S)-6-[(2S)-2,3-dihydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2S,3S,4S,5R,6S)-6-[(2S)-2,3-dihydroxypropoxy]-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C9H18O10S (318.0621)


   

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

C11H15N2O7P-2 (318.0617)


   

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

C11H15N2O7P-2 (318.0617)


   

2-fluoro-N-(8-hydroxy-5-quinolinyl)benzenesulfonamide

2-fluoro-N-(8-hydroxy-5-quinolinyl)benzenesulfonamide

C15H11FN2O3S (318.0474)


   

(11E)-11-diazo-4,9-dihydroxy-2-methylbenzo[b]fluorene-5,10-dione

(11E)-11-diazo-4,9-dihydroxy-2-methylbenzo[b]fluorene-5,10-dione

C18H10N2O4 (318.0641)


   

[(2S,3S,4S,5R,6S)-6-[(2R)-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid

[(2S,3S,4S,5R,6S)-6-[(2R)-2,3-bis(oxidanyl)propoxy]-3,4,5-tris(oxidanyl)oxan-2-yl]methanesulfonic acid

C9H18O10S (318.0621)


   

1,1-Dimethyl-4-phenylpiperazinium iodide

1,1-Dimethyl-4-phenylpiperazin-1-ium iodide

C12H19IN2 (318.0593)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D005731 - Ganglionic Stimulants D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018679 - Cholinergic Agonists

   

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

N-(5-phosphonatopyridoxyl)-D-alaninate(2-)

C11H15N2O7P (318.0617)


Dianion of N-(5-phosphopyridoxyl)-D-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.

   

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

N-(5-phosphonatopyridoxyl)-L-alaninate(2-)

C11H15N2O7P (318.0617)


An organophosphate oxoanion that is the dianion of N-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups with the secondary amino group and pyridine nitrogen protonated.

   

1,7-dihydroxy-3-methyl-6,11-dioxobenzo[b]carbazole-5-carbonitrile

1,7-dihydroxy-3-methyl-6,11-dioxobenzo[b]carbazole-5-carbonitrile

C18H10N2O4 (318.0641)


   

4-hydroxy-3-nitrosobenzaldehyde; 4-hydroxy-3-nitrosobenzoic acid

4-hydroxy-3-nitrosobenzaldehyde; 4-hydroxy-3-nitrosobenzoic acid

C14H10N2O7 (318.0488)


   

4,10-dihydroxy-2-methyl-11-(λ⁵-diazynylidene)cyclohexa[b]fluorene-5,9-dione

4,10-dihydroxy-2-methyl-11-(λ⁵-diazynylidene)cyclohexa[b]fluorene-5,9-dione

C18H10N2O4 (318.0641)


   

[(2s,3s,4s,5r,6s)-6-(2,3-dihydroxypropoxy)-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

[(2s,3s,4s,5r,6s)-6-(2,3-dihydroxypropoxy)-3,4,5-trihydroxyoxan-2-yl]methanesulfonic acid

C9H18O10S (318.0621)


   

4-chloro-1,3-dihydroxy-6-methoxy-8,10-dimethyl-10h-anthracen-9-one

4-chloro-1,3-dihydroxy-6-methoxy-8,10-dimethyl-10h-anthracen-9-one

C17H15ClO4 (318.0659)


   

1,7-dihydroxy-3-methyl-5-(λ⁵-diazynylidene)benzo[a]fluorene-6,11-dione

1,7-dihydroxy-3-methyl-5-(λ⁵-diazynylidene)benzo[a]fluorene-6,11-dione

C18H10N2O4 (318.0641)